Encompass Health issues notice for partial redemption of its 4.500% senior notes due 2028
Rhea-AI Summary
Encompass Health (NYSE:EHC) has issued a notice to redeem $400 million of its 4.500% senior notes due 2028. The notes will be redeemed at 100% of par plus accrued interest, with payment expected on June 15, 2026.
The company expects to record an approximate $3.2 million loss on early extinguishment of debt in Q2 2026, leaving $400 million of these notes outstanding after redemption.
Positive
- Planned redemption of $400 million 4.500% senior notes due 2028
- Redemption at 100% of par plus accrued and unpaid interest
- Aggregate 2028 notes outstanding reduced from $800 million to $400 million
Negative
- Expected $3.2 million loss on early extinguishment of debt in Q2 2026
News Market Reaction – EHC
In the May 15 session, EHC declined 0.62%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 11 | New hospital plan | Positive | +3.1% | Announced plan to build a 50-bed inpatient rehab hospital in Idaho. |
| May 07 | Dividend declaration | Positive | +2.0% | Declared quarterly cash dividend of $0.19 per share. |
| May 05 | Hospital opening | Positive | -0.1% | Opened 50-bed rehab hospital in Concordville, Pennsylvania. |
| Apr 30 | Quarterly earnings | Positive | +7.5% | Q1 2026 revenue, EBITDA, and EPS increased with raised full-year guidance. |
| Apr 23 | Conference participation | Neutral | +0.1% | Announced participation in BofA Securities 2026 Health Care Conference. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent EHC news has often coincided with constructive market reactions, especially around earnings, dividends, and growth initiatives. The Q1 2026 earnings release with higher revenue and Adjusted EBITDA saw a notable positive move, and a subsequent dividend declaration and new hospital plans were also followed by gains. A hospital opening in Pennsylvania produced a slightly negative reaction despite operational expansion, while a conference participation notice had a minimal effect. Overall, investors have tended to respond favorably to growth and capital return updates.
Over the past few weeks, EHC has reported several growth and capital-return milestones. On Apr 30, Q1 2026 results showed higher net operating revenue, Adjusted EBITDA, and EPS, with a 7.48% price gain. A quarterly dividend declaration on May 7 was followed by a 2.04% rise. New and planned rehabilitation hospitals in Pennsylvania and Idaho show continued expansion, with mixed but generally modest price reactions. Today’s debt redemption notice fits into an active capital allocation and growth phase for the company.
Key Terms
senior notes financial
principal balance financial
par financial
accrued and unpaid interest financial
early extinguishment of debt financial
aggregate principal amount financial
trustee financial
redemption price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
The information contained in this press release does not constitute a notice of redemption of the 2028 Notes. Holders of the 2028 Notes should refer to the notice of redemption delivered to the registered holders of the 2028 Notes by Computershare Trust Company, National Association, the trustee with respect to the 2028 Notes.
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in
From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.
Forward-looking statements
Statements contained in this press release which are not historical facts are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant market disruption; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Form 10-Q for the quarter ended March 31, 2026.
Media contact:
Polly Manuel | 205-970-5912
Media@encompasshealth.com
Investor relations contact:
Mark Miller | 205-970-5860
Mark.Miller@encompasshealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-issues-notice-for-partial-redemption-of-its-4-500-senior-notes-due-2028--302772889.html
SOURCE Encompass Health Corp.